Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-072155 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 25, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
90,000
Total Value
$2,770,212.59
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 25, 2026 | Exercise/Conversion | 30,000 | $2.08 | $62,400.00 | 696,195 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 25, 2026 | Sale | 19,764 | $89.78 | $1,774,411.92 | 676,431 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 25, 2026 | Sale | 5,434 | $90.39 | $491,179.26 | 670,997 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 25, 2026 | Sale | 3,293 | $91.76 | $302,165.68 | 667,704 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 25, 2026 | Sale | 1,501 | $92.81 | $139,307.81 | 666,203 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 25, 2026 | Sale | 8 | $93.49 | $747.92 | 666,195 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 25, 2026 | Exercise/Conversion | 30,000 | $0.00 | $0.00 | 245,559 | Direct | โ | View Details |